Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cerilliant
QuintilesIMS
Argus Health
Citi
Fish and Richardson
Colorcon
Covington
McKesson

Generated: May 23, 2018

DrugPatentWatch Database Preview

DURICEF Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Duricef, and when can generic versions of Duricef launch?

Duricef is a drug marketed by Warner Chilcott and is included in three NDAs.

The generic ingredient in DURICEF is cefadroxil/cefadroxil hemihydrate. Twenty-five suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.
Summary for DURICEF
US Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: 63
Clinical Trials: 5
Patent Applications: 3,598
DailyMed Link:DURICEF at DailyMed
Drug patent expirations by year for DURICEF
Synonyms for DURICEF
(6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate
(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate
(6R,7R)-7-[[(2R)-Amino-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Monohydrate
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid--water (1/1)
280111G160
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, monohydrate, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6-alpha,7-beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, monohydrate, (6R-(6-alpha,7-beta(R*)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, monohydrate, (6R-(6alpha,7beta(R*)))-
5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLICACID, 7-[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-3-METHYL-8-OXO-,HYDRATE (1:1), (6R,7R)-
50370-12-2
592C878
66592-87-8
7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetylamino](7R,7aR)-3-methyl-6-oxo-2H,7H-a zetidino[2,1-b]1,3-thiazine-4-carboxylic acid
7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-3,4-didehydrocepham-4-carboxylic acid
7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid
7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid--water (1/1)
AB00513838
AC1L2J3L
AC1L2J3O
AC1Q6LOB
AKOS005622555
AKOS015896360
AN-38430
API0006601
AS-11655
Baxan
Baxan Kapseln
BB_NC-1256
BBL033696
BDBM50350467
Bidocef
Bidocel
BL-S 578
BL-S578
BOEGTKLJZSQCCD-UEKVPHQBSA-N
BPBio1_000494
BSPBio_000448
C-23838
C06878
C16H17N3O5S
CAS-50370-12-2
CC-25549
CCG-220434
CDX
Cefa-Drops
Cefadrops
cefadrox
cefadroxil
Cefadroxil (JP15)
Cefadroxil (JP17)
Cefadroxil (USP)
Cefadroxil [INN]
Cefadroxil [USAN:INN:BAN:JAN]
Cefadroxil [USAN:USP:INN:BAN:JAN]
Cefadroxil 1-wasser
Cefadroxil anhydrous
Cefadroxil monohydrate
Cefadroxil monohydrate, Antibiotic for Culture Media Use Only
Cefadroxil, analytical standard
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Cefadroxilo
Cefadroxilo [INN-Spanish]
Cefadroxilum
Cefadroxilum [INN-Latin]
Cefos Granulat
Cefradroxil
Cephadroxil
CHEBI:3479
CHEBI:53667
CHEMBL1644
CS-4696
CTK8F8512
CTK8F8513
Curisafe (TN)
D-Cefadroxil
D00257
D02353
D0X9ZC
DB01140
DivK1c_000409
DR001942
DR002160
DSSTox_CID_2749
DSSTox_GSID_22749
DSSTox_RID_76714
DTXSID8022749
Duracef
Duricef (TN)
EINECS 256-555-6
Epitope ID:117131
FT-0082620
FT-0603067
GTPL4831
HE255426
HE377271
HMS1569G10
HMS2096G10
HMS501E11
HY-B1190
I04-8441
I06-1925
IDI1_000409
KBio1_000409
KBio2_000544
KBio2_003112
KBio2_005680
KBioGR_000732
KBioSS_000544
Kefroxil Kapseln
LS-149957
MCULE-6475996520
MJF 11567-3
MJF-11567-3
MLS002207219
MolPort-002-507-346
MolPort-003-845-679
Moxacef Kapseln
NBFNMSULHIODTC-CYJZLJNKSA-N
NCGC00016858-01
NCGC00179556-01
NCGC00179556-03
NINDS_000409
NSC-756664
NSC756664
Omnidrox Kapseln
p-Hydroxycephalexine
p-Hydroxycephalexine Monohydrate
Pharmakon1600-01500163
Prestwick0_000434
Prestwick1_000434
Prestwick2_000434
Prestwick3_000434
Q525PA8JJB
RTECS XL9422000
S 578
S-578
SBI-0051305.P003
SC-74593
SCHEMBL151320
SCHEMBL33620
SMR001306770
SPBio_000014
SPBio_002387
Spectrum_000104
Spectrum2_000087
Spectrum4_000266
Spectrum5_000663
ST51014960
ST51053294
STK801939
Sumacef
Sumacef (TN)
Tox21_110651
Tox21_110651_1
Ultracef
UNII-280111G160
UNII-Q525PA8JJB
ZINC3830391

US Patents and Regulatory Information for DURICEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott DURICEF cefadroxil/cefadroxil hemihydrate CAPSULE;ORAL 050512-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Warner Chilcott DURICEF cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 050527-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Warner Chilcott DURICEF cefadroxil/cefadroxil hemihydrate CAPSULE;ORAL 050512-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Warner Chilcott DURICEF cefadroxil/cefadroxil hemihydrate FOR SUSPENSION;ORAL 050527-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cipla
Express Scripts
Fish and Richardson
Merck
Deloitte
Moodys
Johnson and Johnson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.